The Advanced Therapies Congress, scheduled for November 18-19, 2025, at the Pennsylvania Convention Center in Philadelphia, USA, is set to be a pivotal event in the field of cell and gene therapy. This conference, which has been described as America's most exciting commercial cell and gene therapy conference, aims to bring together leaders from pioneering ATMP (Advanced Therapy Medicinal Product) companies and their senior executives to discuss the latest technologies and strategies driving the industry forward.

With over 1,200 attendees expected to participate, the congress offers a unique opportunity for networking and learning. The event will feature 200 speakers from across the entire value chain of cell and gene therapy development, including forward-thinking pharmaceutical companies, biotech firms, researchers, clinicians, academics, HTAs (Health Technology Assessments), payers, and regulators. Notable speakers include Morten Sogaard from Astellas Cokey Nguyen from Atara Biotherapeutics, and Tracy Dowling from AskBio.

The congress is divided into eight tracks of content over two days. These tracks cover a wide range of topics such as evidence-based pricing and access strategies, regulatory challenges at large scale, reimbursement frameworks for market access, cross-border healthcare solutions, and innovative approaches in gene therapy. Attendees will have the chance to explore cutting-edge technologies and learn about the latest academic research in this rapidly evolving field.

In addition to the conference sessions, the exhibition will showcase 50 leading solution providers who cater to all stages of cell and gene therapy development. This provides a platform for companies to meet their needs and collaborate with other industry players.

The event is organized by Terrapinn Holdings Ltd., a member of isla. To sponsor or exhibit at the congress or for more information on speaking opportunities, interested parties can contact Natasha Bangle or Chris Shanks.

Tickets for the Advanced Therapies Congress start from $245. With its focus on innovation and collaboration, this congress promises to be an invaluable resource for professionals in the advanced therapies sector.